Clatterbridge Cancer Centre win BMJ Award for Rectal Cancer Care

Clatterbridge Cancer Center win Prestigious UK Cancer Care Award


A coveted British Medical Journal award was recently bestowed on the Papillon team at The Clatterbridge Cancer Center. The Cancer Care Team category was won by the entry—Papillon for Rectal Cancer.

This life-changing treatment was pioneered by The Clatterbridge Cancer Center when Lead Papillon Clinician Professor Arthur Sun Myint initially introduced the method to the United Kingdom, more than two decades ago. He stated that the honour was the reward for the team’s hard work and their philosophy of always putting patients’ interest first.

Read more

Ariane Medilink Innovation Award

Papillon+ receives Medilink Innovation Award

Medilink Innovation Award – Innovative Cancer Care

The award from Medilink East Midlands recognises our Papillon+ device. For its contribution to improving outcomes for rectal cancer patients.

Because Papillon+ treatments can be completed on an outpatient basis, the Papillon+ x-ray brachytherapy system can reduce treatment times. As well as preventing the need for radical surgery, which often results in a Stoma.

Read more

Papillon Patients in Phase III Opera Trial

The Phase III trial called OPERA which started in France at the end of 2015 has now passed Ethics here in the UK.

Read more

NICE ratify Papillon therapy for rectal cancer

NICE ratify X-ray brachytherapy for Rectal Cancer treatment.

The National Institute of Health & Care Excellence (NICE) have finished their consultation period for the use of Papillon X-Ray Brachytherapy for the treatment of rectal cancer and published their recommendations.

Read more

Phase III Clinical Trial OPERA starts

The Organ Preservation of Early Rectal Adenocarcinoma (OPERA) phase III trial has started to recruit patients at the Centre Antoine-Lacassagne in Nice, France. This Pan-European trial, developed by Prof Jean-Pierre Gerard (Nice) and Prof Arthur Sun Myint (Clatterbridge, UK) is looking to recruit patients across existing Papillon users in France, UK, Sweden, Denmark and Switzerland as well as driving interest in new territories.

Read more

Papillon Training 2016 – 11th & 12th October

The dates for this years 2 day Papillon training course held at the Clatterbridge Cancer Centre, near Liverpool in the UK have been announced. This years training will take place on Tue 11th & Wed 12th October.

The course is open to anyone who is interested in learning all aspects of the Papillon treatment from patient/tumour selection & qualification, through treatment to follow up regimes.

Read more

Arianes’ Papillon X-ray Brachy makes National Press with Nottingham City Hospital

Papillon X-ray Brachy is making national Press, after its NICE ratification, with its use of low energy X-rays to kill cancer cells; allowing better local control of small rectal cancer tumours and offering patients a real alternative to radical surgery and a permanent stoma.

The bowel cancer operation that means you DON’T need a colostomy bag

  • Businesswoman Judith Blount was diagnosed with bowel cancer in 2014 after she noticed blood when she went to the loo
  • Doctors told her she’d need her rectum removed and have to wear a colostomy bag for the rest of her life
  • Instead, she tried a treatment using low-energy radiotherapy called Papillon, which successfully cured her

A new, less invasive form of radiotherapy is now recommended for bowel cancer by the health watchdog. Judith Blount, 49, a businesswoman from Derbyshire, underwent the treatment…

Read more

NICE ratify Papillon low energy X-ray Brachytherapy treatment for UK rectal cancer patients

The National Institute of Health & Care Excellence (NICE) have finished their consultation period for the use of Papillon X-Ray Brachytherapy for the treatment of rectal tumours and published their recommendations..

Read more